StockNews.com Begins Coverage on Arcadia Biosciences (NASDAQ:RKDA)

Analysts at StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research report issued to clients and investors on Tuesday. The brokerage set a “sell” rating on the basic materials company’s stock.

Separately, HC Wainwright reiterated a “buy” rating and issued a $6.00 price objective on shares of Arcadia Biosciences in a report on Wednesday, August 21st.

Arcadia Biosciences Stock Down 0.5 %

Arcadia Biosciences stock opened at $5.87 on Tuesday. The company’s fifty day simple moving average is $3.96 and its 200-day simple moving average is $3.27. Arcadia Biosciences has a 12 month low of $1.85 and a 12 month high of $10.31. The stock has a market cap of $8.01 million, a P/E ratio of -1.37 and a beta of 1.18.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.